Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the mGluR5 Inhibitor Mavoglurant

Clinical trial NCT05203965 · RECRUITING

Trial details

NCT number: NCT05203965
Sponsor: Yale University
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Familial Alcoholism Vulnerability

Start date: 2022-05-17
Primary completion: 2026-07-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.